Sinil Pharmaceutical Co., Ltd. (KOSDAQ: 012790)

Sinil Pharmaceutical Revenue

Sinil Pharmaceutical had revenue of 20.63B KRW in the quarter ending September 30, 2024, a decrease of -18.93%. This brings the company's revenue in the last twelve months to 91.70B, up 6.37% year-over-year. In the year 2023, Sinil Pharmaceutical had annual revenue of 89.14B with 11.41% growth.

• Revenue (ttm): 91.70B
• Revenue Growth: +6.37%
• P/S Ratio: 0.81
• Revenue / Employee: 319.51M
• Employees: 287
• Market Cap: 72.81B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	89.14B	9.13B	11.41%
Dec 31, 2022	80.01B	18.25B	29.56%
Dec 31, 2021	61.75B	316.13M	0.51%
Dec 31, 2020	61.44B	789.70M	1.30%
Dec 31, 2019	60.65B	7.37B	13.84%